深圳信隆健康产业发展股份有限公司 2023 年度审计报告 中国杭州市钱江新城新业路8号UDC时代大厦A座5-8层、12层、23层 Floors 5–8 12 and 23, Block A. UDC Times Building No 8 Xinye Road. Qianjiang New City, Hangzhou Tel. 0571-88879999 Fax. 0571-88879000 www.zhcpa.cn ■ 您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台（http://acc.mo.f.gov.cn）"进行查测。 您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台（http://acc.mo.f.gov.cn）"进行查测。 20 目 | 2K | | --- | | | 页 次 | | --- | --- | | 一、审计报告 | 1-6 | | 二、财务报表 | 7-18 | | (一) 合并资产负债表 | 7-8 | | (二) 合并利润表 | 9 | | (三) 合并现金流量表 | 10 | | (四) 合并所有者权益变动表 | 11-12 | | (五) 母公司资产负债 ...

内部控制审计报告 深圳信隆健康产业发展股份有限公司 内部控制审计报告 中国杭州市钱江新城新业路8号UDC时代大厦A座5-8层、12层、23层 Floors 5–8, 12 and 23, Block A, UDC Times Building. No. 8 Xinye Road. Qianjiang New City, Hangzhou Tel. 0571-88879999 Fax. 0571-88879000 www.zhcpa.cn 中汇会审[2024]4694号 深圳信隆健康产业发展股份有限公司全体股东; 按照《企业内部控制审计指引》及中国注册会计师执业准则的相关要求,我 们审计了深圳信隆健康产业发展股份有限公司(以下简称信隆健康公司)2023年12 月31日的财务报告内部控制的有效性。 一、企业对内部控制的责任 按照《企业内部控制基本规范》、《企业内部控制应用指引》、《企业内部 控制评价指引》的规定,建立健全和有效实施内部控制,并评价其有效性是信隆 健康公司董事会的责任。 二、注册会计师的责任 我们的责任是在实施审计工作的基础上,对财务报告内部控制的有效性发表 审计意见,并对注意到的非财务报告内部控制 ...

深圳信隆健康产业发展股份有限公司 独立董事陈大路 2023 年度述职报告 | 姓名 | 召开股东大会会议次数 | 列席股东大会会议次数 | 备注 | | --- | --- | --- | --- | | 陈大路 | 4 | 4 | —— | 2023年，本人认真参加公司董事会及股东大会，积极了解公司的经营和运作 情况。在每次会议召开前，本人都详细阅读会议资料，为参加会议做好充分的准 备。本人本着勤勉尽责和诚信负责的态度，积极参与讨论并发表独立意见。 1 尊敬的各位股东： 作为深圳信隆健康产业发展股份有限公司的独立董事，本人2023年度严格按 照《中华人民共和国公司法》、《中华人民共和国证券法》、《关于在上市公司 建立独立董事制度的指导意见》、《深圳证券交易所中小板上市公司规范运作指 引》等相关法律法规及本公司《公司章程》中关于独立董事的相关规定，恪尽职 守、勤勉尽责。出席公司董事会和股东大会，了解公司经营发展状况、关注公司 的发展、维护公司的合法权益，对重大事项发表了客观、公正的独立意见。现本 人将2023年履职情况汇报如下： 一、述职第一部分：出席董事会及股东大会情况 本年度，公司共召开了8次董事会会议、 ...

深圳信隆健康产业发展股份有限公司董事会审计委员会 对会计师事务所 2023 年度履职情况评估 及履行监督职责情况的报告 根据《公司法》《证券法》《上市公司治理准则》《国有企业、上 市公司选聘会计师事务所管理办法》《深圳证券交易所上市公司自律 监管指引第 1 号——主板上市公司规范运作》和深圳信隆健康产业发 展有限公司（以下简称"公司"）的《公司章程》《董事会审计委员会 议事规则》等规定和要求，董事会审计委员会本着勤勉尽责的原则， 恪尽职守，认真履职。现将董事会审计委员会对会计师事务所 2023 年度履职评估及履行监督职责的情况汇报如下： 一、2023 年度年审会计师事务所基本情况 中汇会计师事务所于 2013 年 12 月转制为特殊普通合伙，管理总 部设立于杭州，系原具有证券、期货业务审计资格的会计师事务所之 一，长期从事证券服务业务，注册地址浙江省杭州市江干区新业路 8 号华联时代大厦A栋601室，统一社会信用代码91330000087374063A， 执行事务所合伙人余强。 公司对中汇会计师事务所在任期内能按照国家的政策、法规，勤 奋敬业，求真务实，按期保质完成审计工作，并审计公司内控情形， 发挥了中介机 ...

深圳信隆健康产业发展股份有限公司 2023 年度监事会工作报告 一、监事会工作情况 报告期内，监事会严格按照《公司法》、《公司章程》、《监事会议事规则》和有关法律、 法规所赋予的职责和要求，以切实维护公司利益和全体股东权益出发，诚信积极勤勉为原则， 独立认真履行监督职责，通过实地调研和列席、出席董事会、股东大会，了解和掌握公司的 经营决策、投资方案、生产经营情况，对公司董事、总经理和其他高级管理人员的尽职尽责 情况进行了监督，维护了公司利益和全体股东的合法权益。 （一）报告期内，监事会成员列席了 8 次董事会会议。 （二）报告期内，各次股东大会均有监事出席。 报告期内，监事会认真履行《公司法》、《公司章程》等相关法律法规赋予的职权，积极 参加股东大会，列席董事会会议，对公司 2023 年依法运作情况进行监督，认为：公司依照国 家有关法律法规、公司章程的规定以及股东大会、董事会的决议和授权规范运作，决策科学 合理，程序合法，法人治理结构和内部控制制度比较合理规范；公司董事、高级管理人员执 行职务时能够勤勉尽责，认真履行股东大会和董事会的决议，未发现违反法律法规、公司章 程或损害公司利益和股东合法权益的行为。对此 ...

深圳信隆健康产业发展股份有限公司 2024年日常关联交易计划公告 证券代码：002105 证券简称：信隆健康 公告编号：2024-011 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、日常关联交易基本情况 （一）日常关联交易概述 深圳信隆健康产业发展股份有限公司（以下简称"公司"）为应经营发展需要，公司预计 2024年度将与信隆车料工业股份有限公司（以下简称"台湾信隆"）、艾跃炫贸易（上海）有 限公司（以下简称"艾跃炫"）发生销售产品、采购商品的关联交易事项，预计2024年关联交 易总额不超过1,800万元，上年度公司与关联方发生的日常关联交易总额为609.30万元。公司 就2024年度拟与关联方之间开展的关联交易计划，编制了《深圳信隆健康产业发展股份有限公 司2024年度日常关联交易计划》，公司于2024年4月18日召开独立董事专门会议2024年第一次 会议，全体独立董事一致通过《关于<2024年度日常关联交易计划>的议案》并将《深圳信隆健 康产业发展股份有限公司2024年度日常关联交易计划》提请公司2024年4月22日召开的第七届 董事会第八次会议审 ...

证券代码：002105 证券简称：信隆健康 公告编号： 2024-013 公司将在 2023 年年度报告网上说明会上，在信息披露允许的范围内对投资者普遍 关注的问题进行回答。活动交流期间，投资者仍可登陆活动界面进行互动提问。 深圳信隆健康产业发展股份有限公司 关于 2023 年年度报告网上说明会公开征集问题的 提示性公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 深圳信隆健康产业发展股份有限公司(以下简称"公司")已于 2024 年 4 月 24 日发 布了公司《2023 年年度报告》并于同日披露了《关于举办 2023 年年度报告网上业绩说 明会的公告》。公司将于 2024 年 5 月 17 日（星期五）下午 15:00-17:00 在全景网"投 资者关系互动平台"http://irm.p5w.net 举行 2023 年年度报告网上说明会。 为充分尊重投资者，提升交流的针对性，现就公司 2023 年年度报告网上说明会提 前向投资者公开征集问题，广泛听取投资者的意见和建议。投资者可于 2024 年 5 月 14 日 17:00 前访问 https://ir ...

证券代码：002105 证券简称：信隆健康 公告编号：2024-012 深圳信隆健康产业发展股份有限公司 关于举行2023年年度报告网上说明会的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误 导性陈述或重大遗漏。 深圳信隆健康产业发展股份有限公司（以下简称：公司）将于2024年5月17日（星期五）下午 15:00-17:00 在全景网"投资者关系互动平台"举行2023年年度报告网上说明会，本次说明会将 采用网络远程方式举行，投资者可登陆投资者互动平台：http://irm.p5w.net 参与本次说明会。 公司出席本次说明会的人员有：公司董事长廖学金先生、董事会秘书陈丽秋女士、财务总监 邱东华先生、独立董事高海军先生。 欢迎广大投资者积极参与！ 特此公告。 深圳信隆健康产业发展股份有限公司董事会 2024年4月24日 ...

2024 年 4 月 22 日 董事会关于独立董事独立性自查情况的专项意见 根据中国证券监督管理委员会《上市公司独立董事管理办法》《深圳证券交易所股票上市 规则》《深圳证券交易所上市公司自律监管指引第 1 号——主板上市公司规范运作》等要求， 深圳信隆健康产业发展股份有限公司（以下简称"公司"）董事会，就公司在任独立董事高 海军先生、陈大路先生、王巍望女士、甘勇明先生的独立性情况进行评估并出具如下专项意 见： 经核查独立董事高海军先生、陈大路先生、王巍望女士、甘勇明先生的任职经历以及签 署的相关自查文件，上述人员未在公司担任除独立董事以外的任何职务，也未在公司主要股 东公司担任任何职务，与公司以及主要股东之间不存在利害关系或其他可能妨碍其进行独立 客观判断的关系，不存在影响独立董事独立性的情况，符合《上市公司独立董事管理办法》 《深圳证券交易所上市公司自律监管指引第 1 号——主板上市公司规范运作》中对独立董事 独立性的相关要求。 深圳信隆健康产业发展股份有限公司 董事会 深圳信隆健康产业发展股份有限公司 ...

U.S. Bicycle Market Trends - The U.S. bicycle market faces high inventory levels in 2023 due to explosive consumption during 2020-2022, with sales weakened by interest rate hikes and high inflation. Brands are offering 30%-40% discounts to clear inventory, putting pressure on small and medium brands[30] - U.S. e-bike sales surpassed 1 million units in 2023, growing 25% YoY. The North American e-bike market is projected to reach $4.1 billion by 2028[36] European E-bike Market Trends - The European e-bike market is projected to reach 12 million units by 2030, with a shift towards leisure, short-distance commuting, and intelligent transportation. Traditional bicycle demand is declining sharply[31] - European e-bike market inventory remains high, with 30%-40% discounts offered. The UK reduced anti-dumping duties on Chinese e-bikes from 62.1% to 16.2%, with a total tax rate of 33.4%[37] Global E-bike Market Growth - The global e-bike market is expected to grow from $28.9 billion in 2023 to $52.6 billion by 2028, with a 12% CAGR. The e-cargo bike market reached $2.04 billion in 2023[35] Company Market Position and Competitors - The company holds 25% of the global bicycle control parts market and 15% of the suspension fork market, with main competitors being Suntour (70%) and RST (10%)[39] - Competitor SR has expanded production capacity in Germany and Taiwan, with 6 service centers in Germany, strengthening its local presence[41] Shared Mobility Challenges - The U.S. shared e-scooter market faces challenges, with Bird Global filing for bankruptcy in December 2023[42] - European e-scooter shipments declined 50%-70% in 2023, with Xiaomi reducing its annual budget by over 90%, cutting approximately 900,000 units[44] Shipping and Logistics - Red Sea shipping crisis caused container shipping rates to surge by nearly 600%, with rates for a 40-foot container exceeding $10,000[49] - Shanghai to US West Coast shipping rates rose 43.2% to $3,974/FEU, while Shanghai to US East Coast rates increased 47.9% to $5,813/FEU[50] - New FAK rates effective January 15 set 40-foot container rates at $5,000 for US West Coast and $7,000 for East Coast/Gulf ports[51] Shared Mobility Mergers and Market Leaders - Tier Mobility and Dott merger expected to create Europe's largest shared mobility operator with combined revenue exceeding €200 million[52][54] - Ninebot maintains China's top position in smart two-wheeled electric vehicles with leading sales in 4000+/5000+ RMB premium segments[56] - Ninebot's global electric scooter production surpassed 10 million units, with 2.3 million units sold in 2020, accounting for 85% of China's total production[59] Global Electric Scooter Market Forecast - QY Research forecasts global electric scooter production to reach 10.01 million units by 2027, with a market value of $3.34 billion[59] - Boston Consulting Group predicts global smart electric scooter market could reach $50 billion by 2025, with $15 billion in Europe/US and $8 billion in China[59] Micromobility Trends in Australia - Australia's micromobility market grew fivefold since 2017, with over 250,000 personal electric scooters in use[60] - 97% of Australian users find electric scooters more enjoyable than e-bikes, with 85% using them for leisure and 30% planning to increase usage[60] Electric Scooter Market in Russia - Electric scooter sales in Russia increased by 43% year-on-year, reaching 245,000 units in Q1 2023[62] - 85% of personal mobility vehicle purchases in Russia are electric scooters, with 10% being electric bicycles[62] - Shared electric scooter users in Russia aged 50+ increased by 84% over the past year[63] Elderly and Disabled Assistive Devices Market - The global elderly and disabled assistive devices market is projected to reach 299.31 billion yuan by 2030, with a CAGR of 9.11% from 2023[69] - North America holds the largest share of the global wheelchair market at 32.47% in 2023[69] - The Asia-Pacific region is the fastest-growing wheelchair market, expected to grow at a CAGR of 11.8% from 2023 to 2028[73] Rehabilitation Medical Device Market in China - China's rehabilitation medical device market is projected to reach 67 billion yuan by 2023, growing at a CAGR of 19.1%[74] - Global electric wheelchair retail sales are expected to reach 322.023 billion yuan in 2023, a 48.3% increase from 2022[75] - Smart electric wheelchair production is expected to reach 183.021 billion yuan in 2023, a 58.4% increase from 2022[75] - China's electric wheelchair production reached approximately 2.56 million units in 2022[75] Financial Performance and Revenue Decline - Total operating revenue decreased by 47.18% to RMB 963.92 million in 2023 compared to RMB 1.82 billion in 2022[90] - Bicycle parts revenue dropped by 55.47% to RMB 666.58 million, accounting for 69.15% of total revenue[90] - Sports and fitness rehabilitation equipment revenue decreased by 9.02% to RMB 283.47 million, making up 29.41% of total revenue[90] - Domestic sales accounted for 42.06% of total revenue, decreasing by 37.81% to RMB 405.39 million[90] Production and Sales Volume Decline - Bicycle parts sales volume fell by 54.47% to 2.01 million units, with production volume dropping by 58.82% to 1.78 million units[93] - Sports and fitness rehabilitation equipment sales volume decreased by 11.07% to 208,100 units, with production volume down by 5.98% to 195,100 units[93] Customer and Supplier Concentration - Top five customers contributed 35.15% of total sales, with the largest customer accounting for 16.54% of total revenue[99][100] - Top five suppliers accounted for 16.03% of total procurement, with the largest supplier contributing 3.61%[100] Subsidiary Establishment and R&D - The company established a new subsidiary, Shenzhen Laiqi Technology Co., Ltd., in October 2023 with a registered capital of RMB 10 million[98] - R&D expenses decreased by 19.44% to RMB 45.58 million in 2023 compared to RMB 56.58 million in 2022[102][104] - R&D personnel decreased by 13.25% to 406 in 2023 from 468 in 2022, with a slight increase in R&D personnel ratio to 16.76%[103] Cash Flow and Financial Activities - Operating cash flow decreased by 25.59% to RMB 274.81 million in 2023 from RMB 369.32 million in 2022[105] - Investment cash inflow surged by 2311.38% to RMB 58.79 million in 2023 due to the recovery of structured deposits[106] - Investment cash outflow increased by 112.83% to RMB 170.11 million in 2023, mainly due to increased cash expenditures on fixed assets[106] - Net cash flow from financing activities improved by 33.86% to a negative RMB 172.31 million in 2023[106] Profit and Non-Operating Income - Net profit was RMB 18.34 million, significantly lower than the operating cash flow of RMB 276.22 million, mainly due to reduced inventory and lower depreciation expenses[107] - Non-operating income reached RMB 24.15 million, accounting for 172.78% of total profit, primarily from temporary relocation fees[109] - Asset impairment losses amounted to RMB 6.49 million, accounting for 46.42% of total profit, mainly due to inventory obsolescence and idle fixed assets[109] - Government subsidies contributed RMB 1.60 million, accounting for 11.43% of total profit[109] Strategic Goals and Market Expansion - Revenue growth is the primary goal, with a focus on new product development and new customer acquisition[155] - Actively visiting overseas customers to develop new business opportunities[155] - Participating in domestic medical exhibitions to expand the domestic market[155] - Investing in the development of manual and electric wheelchair ODM products[155] - Developing proprietary ODM products, such as electric wheelchairs with lifting mechanisms[155] - Establishing a cost reduction project to meet customer pricing requirements[155] - Optimizing business and operational management processes to prepare for future growth[155] Export Sales and Tariff Impact - Direct export sales accounted for 64.28% of total sales in 2022[156] - Bicycle parts exports are indirectly affected by US tariffs but not by EU anti-dumping duties[156] Corporate Governance and Independence - The company has established a comprehensive internal audit system, with an internal audit institution reporting directly to the Board Audit Committee, ensuring independence and effectiveness in auditing internal controls and financial activities[170] - The company maintains complete independence in assets, personnel, finance, organization, and business operations, with no reliance on shareholders for production or business premises[172] - The company's personnel, including directors, supervisors, and senior management, are independently appointed and remunerated, with no overlap in roles with shareholders or related enterprises[173] - The company has an independent financial department established since 1991, adhering to the "Enterprise Accounting Standards" and maintaining separate bank accounts and tax filings[174] - The company operates independently in its core business of bicycle parts and sports fitness rehabilitation equipment, with no overlap in business activities with shareholders or related enterprises[175] Shareholder Meetings and Resolutions - The 2022 Annual General Meeting had a 51.17% investor participation rate, with key resolutions including the approval of the 2022 financial report and profit distribution plan[176] Executive Compensation - The company strictly adheres to the "Compensation System for Directors, Supervisors, and Senior Management," with actual compensation for 2023 approved by the Remuneration and Assessment Committee and disclosed in the 2023 annual report[199] - Each director/supervisor receives an annual remuneration of 120,000 RMB (after tax deduction), paid monthly, with taxes withheld by the company[199] - The remuneration for directors and supervisors was revised and approved at the 2022 first extraordinary general meeting, effective from May 2022[199]